Logo
D

Digital Diagnostics

112 employees

Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform the quality, accessibility and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product IDx-DR, an autonomous AI system FDA-authorized to diagnose diabetic retinopathy and diabetic macular edema, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare. Digital Diagnostics is hiring! Learn more about our featured roles and other open positions here: www.digitaldiagnostics.com/careers/

Investor insights

Funding rounds participated in

$75M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Medical Equipment Manufacturing

Sectors

Medical Equipment Manufacturing

Date founded

2010

Funding rounds raised

Total raised

$75M

from 2 investors over 1 rounds

D

Digital Diagnostics raised $75M on September 23, 2022

Investors: Kohlberg Kravis Roberts and + 7 Other investors

FAQ